Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Menbutone
Alvetra u. Werfft GmbH
QA05AX90
Menbutone
100 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Goats, Horses, Pigs, Sheep
menbutone
Alimentary Tract Preparation
Authorised
2017-03-24
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Alvebuton 100 mg/ml Solution for injection for cattle, pigs, horses, sheep, goats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Menbutone ............................. 100.00 mg EXCIPIENTS: Chlorocresol................................ 2.00 mg Sodium metabisulfite (E 223)..... 2.00 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear, pale yellow to yellow solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, pigs, horses, sheep, goats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle, pigs, horses, sheeps, goats: Stimulation of hepato-digestive activity in case of digestive disorders and hepatic insufficiency. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in animals with cardiac disease or in the late stages of pregnancy. Please refer to section 4.7 “Use during pregnancy, lactation or lay”. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals For horses only intravenous administration. The intravenous administration should be done slowly (not less than 1 minute) to avoid the side effects described in section 4.6. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Accidental self-injection can induce irritation. People with known hypersensitivity to menbutone should avoid contact with the veterinary medicinal product. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Read the complete document